Safety

Just 8 years after the development of CRISPR-Cas technology, Vertex Pharmaceuticals and CRISPR Therapeutics share positive clinical data for their ex...

With the Nobel Prize in Chemistry being awarded to the founding mothers of CRISPR - Emmanuelle Charpentier and Jennifer Doudna - genome editing is...

In this roundup, we look back on our interviews with scientists who are making strides in developing CRISPR-based cures for genetic diseases.

CRISPR is believed to hold the cure for many rare single-gene disorders that are otherwise incurable. Alessia Cavazza’s group at University College...

Using massively parallel kinetic profiling, scientists can now characterise the cleavage and binding specificity of Cas variants for 10,000 targets at...

CRISPR genome editing marches forward as a curative therapy for genetic disorders. Here lead scientist Ayal Hendel talks about how he is developing a...

We have added a new cancer immunotherapy trial by CRISPR Therapeutics to our overview of current clinical trials involving gene editing.

Scientists use CRISPR to change the fate of adipocytes, so bad fat is turned into good fat. Effectively treating fat with fat, this might help...